|
|
Volumn 31, Issue 1-2, 1999, Pages 882-883
|
|
Use of gene therapy for tolerogenic signals
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD18 ANTIGEN;
CD2 ANTIGEN;
CD45 ANTIGEN;
INTERLEUKIN 4 ANTIBODY;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
RECOMBINANT INTERLEUKIN 10;
T LYMPHOCYTE ANTIGEN;
VIRUS VECTOR;
ADENOVIRUS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIGEN DETECTION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
GENE REPRESSION;
GENE THERAPY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART GRAFT;
IMMUNOLOGICAL TOLERANCE;
IMMUNOSUPPRESSIVE TREATMENT;
LYMPHOCYTE COUNT;
MOLECULAR DYNAMICS;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
T LYMPHOCYTE SUBPOPULATION;
TREATMENT OUTCOME;
VIRUS IMMUNITY;
ADENOVIRIDAE;
ANIMALS;
GENE THERAPY;
GENETIC VECTORS;
GRAFT REJECTION;
HEART TRANSPLANTATION;
IMMUNOSUPPRESSION;
INTERLEUKIN-10;
MICE;
PLASMIDS;
RETROVIRIDAE;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0032986226
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01816-8 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (4)
|
